- Home
- NVAX vs SPH Comparison
NVAX vs SPH Comparison
Compare NVAX & SPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVAX
- SPH
- Stock Information
- Founded
- NVAX 1987
- SPH 1945
- Country
- NVAX United States
- SPH United States
- Employees
- NVAX N/A
- SPH N/A
- Industry
- NVAX Biotechnology: Biological Products (No Diagnostic Substances)
- SPH Other Specialty Stores
- Sector
- NVAX Health Care
- SPH Consumer Discretionary
- Exchange
- NVAX Nasdaq
- SPH Nasdaq
- Market Cap
- NVAX 1.3B
- SPH 1.2B
- IPO Year
- NVAX 1995
- SPH 1996
- Fundamental
- Price
- NVAX $7.84
- SPH $18.69
- Analyst Decision
- NVAX Hold
- SPH Sell
- Analyst Count
- NVAX 6
- SPH 1
- Target Price
- NVAX $15.00
- SPH $17.00
- AVG Volume (30 Days)
- NVAX 8.6M
- SPH 152.4K
- Earning Date
- NVAX 08-06-2025
- SPH 08-07-2025
- Dividend Yield
- NVAX N/A
- SPH 6.96%
- EPS Growth
- NVAX N/A
- SPH N/A
- EPS
- NVAX 2.54
- SPH 1.49
- Revenue
- NVAX $1,078,718,000.00
- SPH $1,429,783,000.00
- Revenue This Year
- NVAX $52.02
- SPH $10.99
- Revenue Next Year
- NVAX N/A
- SPH N/A
- P/E Ratio
- NVAX $3.08
- SPH $12.54
- Revenue Growth
- NVAX 9.22
- SPH 6.29
- 52 Week Low
- NVAX $5.01
- SPH $16.92
- 52 Week High
- NVAX $15.22
- SPH $22.24
- Technical
- Relative Strength Index (RSI)
- NVAX 48.26
- SPH 55.15
- Support Level
- NVAX $7.57
- SPH $17.30
- Resistance Level
- NVAX $10.64
- SPH $18.75
- Average True Range (ATR)
- NVAX 0.72
- SPH 0.47
- MACD
- NVAX -0.07
- SPH 0.04
- Stochastic Oscillator
- NVAX 29.47
- SPH 95.86
About NVAX Novavax Inc.
Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.
About SPH Suburban Propane Partners L.P.
Suburban Propane Partners LP distributes propane, fuel oil, and other refined fuels to customers in the East Coast and West Coast regions of the United States. Other operations include natural gas and electricity marketing in the deregulated New York and Pennsylvania markets. The company operates in three segments: Propane; Fuel Oil and Refined Fuels; and Natural Gas and Electricity. It generates maximum revenue from Propane segment.